• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    FibroGen, Inc - Common Stock (NQ: FGEN )

    0.4000 +0.0463 (+13.09%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,372,259
    Open 0.3500
    Bid (Size) 0.4198 (1)
    Ask (Size) 0.4300 (7)
    Prev. Close 0.3537
    Today's Range 0.3466 - 0.4250
    52wk Range 0.1800 - 2.930
    Shares Outstanding 98,210,168
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Are Chip Stocks Up Today?
    Chip stocks are up today and investors wondering why will find all of the news explaining the rally in the sector on Wednesday. 
    Via InvestorPlace
    FibroGen Layoffs 2024: What to Know About the Latest FGEN Job Cuts
    FibroGen layoffs are in the news Wednesday after the biopharmaceutical company announced plans to cut jobs after failed clinical trials. 
    Via InvestorPlace
    Topics Workforce
    Exposures Layoff

    Performance

    YTD
    -51.84%
    -51.84%
    1 Month
    +1.16%
    +1.16%
    3 Month
    +7.50%
    +7.50%
    6 Month
    -66.67%
    -66.67%
    1 Year
    -49.90%
    -49.90%

    More News

    Read More
    Why is Macrogenics (MGNX) Stock Down 28% Today?
    Via InvestorPlace
    Why Is FibroGen (FGEN) Stock Down 44% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Earnings Scheduled For November 12, 2024
    Via Benzinga
    Earnings Outlook For FibroGen
    Via Benzinga
    FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
    Via Benzinga
    Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    One Year, Five Trial Failures: FibroGen Terminates Pancreatic Cancer Treatment Program
    Via Benzinga
    Ground Cinnamon Recalls: What to Know as FDA Issues Alert Over Lead Levels
    Via InvestorPlace
    Topics Product Recall
    Exposures Legal Product Safety
    Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    What's Going On With FibroGen Stock Tuesday?
    Via Benzinga
    Exposures Product Safety
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    FibroGen Stock Is Surging After The Bell: What's Going On?
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    7 Penny Biotech Stocks to Triple Your Investment
    Via InvestorPlace
    Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
    Via AB Newswire
    Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    FibroGen Shares Climb On Strong Q1 Sales
    Via Benzinga
    Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.